Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LumenVox is a leading provider of AI-driven speech recognition and voice biometrics technology, specializing in secure and accurate voice authentication for highly regulated industries such as healthcare and financial services. Founded in 2001 and headquartered in San Diego, the company offers a suite of core speech technologies, including automated speech recognition (ASR), text-to-speech (TTS), and multifactor biometric authentication. In the healthcare sector, LumenVox's solutions are used to automate patient interactions, such as appointment scheduling and prescription refills, while ensuring HIPAA compliance through secure voiceprint verification. The company's technology is integrated into major communication platforms and is powered by advanced deep neural networks. In September 2023, LumenVox was acquired by Capacity, an AI-powered support automation platform, to further expand its voice automation and omnichannel engagement capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LumenVox.